Renal effects of drugs used in the treatment of portal hypertension

Hepatology. 1993 Sep;18(3):688-95.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Calcium Channel Blockers / pharmacology
  • Calcium Channel Blockers / therapeutic use
  • Diuretics / pharmacology
  • Diuretics / therapeutic use
  • Humans
  • Hypertension, Portal / drug therapy*
  • Kidney / drug effects*
  • Kidney / physiopathology
  • Nitrates / pharmacology
  • Nitrates / therapeutic use
  • Somatostatin / pharmacology
  • Somatostatin / therapeutic use
  • Vasodilator Agents / pharmacology
  • Vasodilator Agents / therapeutic use
  • Vasopressins / pharmacology
  • Vasopressins / therapeutic use

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Diuretics
  • Nitrates
  • Vasodilator Agents
  • Vasopressins
  • Somatostatin